×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Sastasundar Ventures Limited | 3.54 | -1.09 | 0.97 | -0.03 | 863.0 | 24.0 |
| ANUH PHARMA LTD. | 1898.68 | 83.01 | 1864.79 | 1.66 | 862 | 18.7 |
| IND-SWIFT LABORATORIES LTD. | 1673.16 | 87.75 | 1527.34 | 1.17 | 783 | 35.5 |
Sastasundar Ventures Limited, with Security Code 533259, is a leading player in the Healthcare Service Provider industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2024 | Sep 2024 | Dec 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.1 | 0.2 | 0.0 | 0.3 | 0.6 | 0.4 | 0.1 | 0.1 | 0.1 | 0.1 |
| Expenses | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.5 | 0.5 | 0.6 | 0.4 | 0.4 |
| Operating Profit | -0.4 | -0.3 | -0.4 | -0.2 | 0.0 | -0.1 | -0.4 | -0.5 | -0.3 | -0.3 |
| OPM % | -321.1% | -174.43% | -990.91% | -75.75% | 1.36% | -23.67% | -506.1% | -426.79% | -255.14% | -295.88% |
| Other Income | 9.6 | 5.0 | 0.1 | 0.8 | 1.0 | 0.1 | 0.2 | 0.2 | 0.2 | 0.3 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| Depreciation | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit before tax | 0.0 | -0.1 | -0.4 | 0.6 | 0.8 | 0.0 | -0.2 | -0.3 | -0.1 | -0.1 |
| Tax % | -19.2% | -4.5% | 0% | -6.8% | -21.2% | -48.9% | 0% | 0% | 0% | 0% |
| Net Profit | 7.4 | 4.5 | -0.4 | 0.5 | 0.8 | 0.0 | -0.2 | -0.3 | -0.1 | -0.1 |
| EPS in Rs | 2.33 | 1.4 | -0.12 | 0.16 | 0.25 | -0.01 | -0.07 | -0.1 | -0.03 | -0.03 |
| Metrics | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 34.4 | 38.4 | 35.8 | 43.7 | 46.7 | 49.7 | 53.9 | 55.5 | 59.4 | 285.8 |
| Expenses | 40.8 | 43.9 | 38.8 | 45.1 | 51.7 | 56.2 | 60.5 | 64.5 | 74.7 | 311.0 |
| Operating Profit | -6.4 | -5.5 | -3.0 | -1.3 | -5.1 | -6.4 | -6.7 | -9.0 | -15.4 | -25.2 |
| OPM % | -18.63% | -14.3% | -8.44% | -2.99% | -10.89% | -12.94% | -12.39% | -16.17% | -25.84% | -8.81% |
| Other Income | 2.6 | 0.8 | 0.7 | 6.1 | 1.6 | 0.2 | 1.0 | 1.0 | 0.3 | 21.9 |
| Interest | 1.1 | 0.9 | 0.0 | 0.1 | 0.2 | 0.4 | 0.5 | 0.6 | 0.2 | 0.0 |
| Depreciation | 1.9 | 1.6 | 1.3 | 1.4 | 1.5 | 1.5 | 1.6 | 1.5 | 1.5 | 1.3 |
| Profit before tax | -6.9 | -7.2 | -3.7 | -2.1 | -6.2 | -8.1 | -7.8 | -10.1 | -16.7 | -4.9 |
| Tax % | 3.2% | 2.3% | 4.8% | -57% | 1.8% | 2.2% | 2.8% | 3.9% | 1.2% | 479.1% |
| Net Profit | -7.1 | -7.3 | -3.9 | 1.5 | -5.2 | -8.3 | -8.0 | -10.5 | -16.9 | 17.6 |
| EPS in Rs | -2.24 | -2.2 | -0.97 | 0.68 | -1.33 | -2.34 | -2.17 | -2.87 | -4.64 | 4.3 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -16% |
| 5 Years: | -29% |
| 3 Years: | 17% |
| TTM: | 80% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | -396% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 33% |
| 3 Years: | -6% |
| 1 Year: | -13% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 47% |
| 5 Years: | 45% |
| 3 Years: | 38% |
| TTM: | -18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 17% |
| 3 Years: | 37% |
| TTM: | 204% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 33% |
| 3 Years: | -6% |
| 1 Year: | -13% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|